Opportunity states: "Why is Goldseeker suddenly MIA? Could he be trading biocurex shares? Hmmmmm. You be the judge."
Nope, not trading the stock. As I said, I will never buy any of this stock again. If you had read my previous post, I told you I was rather busy today.
Now, as far as this press release, it would have indeed been exciting if they had been able to detect cancer in its early stages where it is treatable. It obviously CANNOT detect cancer in its early stages or that would have been announced. Why select your test subjects from amoungst those patients that are not far from death? Common sense would tell you that they also attempted to detect cancer in saliva in earlier stage cancer but wasn't able to. BTW, it is no wonder that you could detect cancer with RECAF in advanced stages of cancer. By that time it is spread nearly everywhere in the body. Would you be surprised to find it in saliva at that point. Not at all. What was surpirsing was that it was not 100% sensitive and 100% specific at a point where cancer is throughout the body. (87% sensitivity and 91% specificity)
The question is why even announce something like this?
